Literature DB >> 2255678

Effects of pinacidil upon penile erectile tissue, in vitro and in vivo.

A Giraldi1, G Wagner.   

Abstract

The effect of pinacidil, a new antihypertensive vasodilator, was studied in vitro upon human and porcine Corpus cavernosum and in vivo upon simian Corpus cavernosum. In vitro, pinacidil incubation (10(-5)-10(-3) M) was found to induce a concentration-dependent inhibition of the tissue response to norepinephrine (NE) and high potassium (K+). Likewise a concentration-related relaxation of the tissue, precontracted with either NE or K+, was seen using pinacidil 10(-5)-10(-3) M. Depending on the concentration applied, spontaneous activity as well as tone and amplitude of the contractions were reduced until total relaxation of the tissue was obtained with a pinacidil incubation of 10(-3) M. In vivo, 5 mg pinacidil in 0.3 ml solution was injected intracavernosally in 17 monkeys. Sixteen monkeys developed tumescence and 10, rigidity of the penis as well. Only one of 5 showed a decrease in the systemic blood pressure. Pinacidil might be of clinical interest as an agent facilitating erection when given intravernosally.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2255678     DOI: 10.1111/j.1600-0773.1990.tb00819.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  3 in total

1.  Potassium channel agonists cause penile erection in cats.

Authors:  Wayne J G Hellstrom; Run Wang; Philip J Kadowitz; Floyd R Domer
Journal:  Int J Impot Res       Date:  1992       Impact factor: 2.896

Review 2.  Intracavernous pharmacotherapy.

Authors:  M C Truss; A J Becker; D Schultheiss; U Jonas
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  The sGC activator BAY 60-2770 has potent erectile activity in the rat.

Authors:  George F Lasker; Edward A Pankey; Terrence J Frink; Jonathan R Zeitzer; Korey A Walter; Philip J Kadowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.